Showing results (2771-2780 of 8,035) with videos related to
Sort By:
Pageof 804
Current Medicinal Chemistry|November 6, 2007
The many roles of chemokine receptors in neurodegenerative disorders: emerging new therapeutical strategiesMarjelo Mines, Yun Ding, Guo-Huang FanCurrent Medicinal Chemistry|November 6, 2007
Tight junction modulators: promising candidates for drug deliveryM Kondoh, K YagiCurrent Medicinal Chemistry|November 6, 2007
New therapeutic strategies for coeliac disease: tissue transglutaminase as a targetCarla Esposito, Ivana Caputo, Riccardo TronconeCurrent Medicinal Chemistry|June 23, 2007
Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indicationsHeike Wulff, Aaron Kolski-Andreaco, Ananthakrishnan Sankaranarayanan, et al.Current Medicinal Chemistry|June 23, 2007
Dual action-based approaches to antibacterial agentsJohn B Bremner, Joseph I Ambrus, Siritron SamosornCurrent Medicinal Chemistry|June 23, 2007
Tumor necrosis factor-alpha monoclonal antibodies for Crohn's disease: tipping the balanceSilvio Danese, Nico Pagano, Erika Angelucci, et al.Current Medicinal Chemistry|June 23, 2007
Co-treatment with copper compounds dramatically decreases toxicities observed with cisplatin cancer therapy and the anticancer efficacy of some copper chelates supports the conclusion that copper chelate therapy may be markedly more effective and less toxic than cisplatin therapyJohn R J Sorenson, Grant W WangilaCurrent Medicinal Chemistry|June 23, 2007
Molecular probes for P2X7 receptor studiesHendra Gunosewoyo, Mark J Coster, Michael KassiouCurrent Medicinal Chemistry|June 23, 2007
Hypokalemia: a practical approach to diagnosis and its genetic basisShih-Hua Lin, Mitchell L HalperinPageof 804